Skip to main content

Advertisement

Log in

Clinical evaluation of a commercial ligase-based gene amplification method for detection ofMycobacterium tuberculosis

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate the clinical usefulness of a commercial ligase-based gene amplification method (LCxMycobacterium tuberculosis test; Abbott Laboratories, USA) for detection ofMycobacterium tuberculosis. The tuberculosis infection rate among clinical samples was 10.6%. The sensitivity, specificity, and positive and negative predictive values were 23.5%, 100%, 100%, and 91.7%, respectively, with the fluorochrome auramine stain; 32.4%, 100%, 100%, and 92.6%, respectively, with culture; and 76.5%, 95.8%, 68.4% and 97.2%, respectively, with the gene amplification method. When only samples from patients without current or previous treatment were studied, the sensitivity was 36.4% with the auramine stain, 63.6% with culture, and 100% with the gene amplification assay. The mean treatment time for culture-negative and assay-negative samples was greater than that of culture-negative and assay-positive samples. The LCxMycobacterium tuberculosis test is a sensitive method for detection and identification ofMycobacterium tuberculosis. It produces few false-positive results. However, as it can remain positive after the culture becomes negative, it is not recommended for evaluation of treatment efficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. World Health Organization: Tuberculosis notification update. Weekly Epidemiological Record (1996) 71:65–69

    Google Scholar 

  2. Kochi A: The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle (1991) 72:1–6

    PubMed  Google Scholar 

  3. Centers for Disease Control: Tuberculosis morbidity — United States 1991. Morbidity and Mortality Weekly Report (1992) 41:240

    Google Scholar 

  4. de March Ayuela P: Situación actual de la tuberculosis en España. Medicina Clínica (1991) 97:463–472

    Google Scholar 

  5. Millard FJC: The rising incidence of tuberculosis. Journal of the Royal Society of Medicine (1996) 89:497–500

    PubMed  Google Scholar 

  6. Centers for Disease Control: Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons. Florida and New York, 1988. Morbidity and Mortality Weekly Report (1991) 40:585–591

    Google Scholar 

  7. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams JN, Sordillo ME, Ong KR, Kilburn JO, Dooley SW, Castro KG: An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. New England Journal of Medicine (1992) 326:1514–1521

    PubMed  Google Scholar 

  8. Grupo de Estudio de Tuberculosis Resistente de Madrid: Estudio transversal multihospitalario de tuberculosis y resistencias en Madrid (octubre 1993–abril 1994). Medicina Clínica (1996) 106:1–6

    Google Scholar 

  9. Centers for Disease Control: National action plan to combat multidrug resistant tuberculosis. Morbidity and Mortality Weekly Report (1994) 41:1–48

    Google Scholar 

  10. Tenover FJ, Crawford JT, Huebner RE, Geiter LJ, Harsburgh CR, Good RC: The resurgence of tuberculosis: is your laboratory ready? Journal of Clinical Microbiology (1993) 32:767–770

    Google Scholar 

  11. Grupo de Trabajo sobre Tuberculosis: Consenso nacional para el control de la tuberculosis en España. Medicina Clínica (1992) 98:24–31

    Google Scholar 

  12. Hall GS: Primary processing of specimens and isolation and cultivation of mycobacteria. In: Heifits LB (ed): Clinics in laboratory medicine. WB Saunders, Philadelphia (1996) pp. 551–567

    Google Scholar 

  13. Roberts GD, Böttger EC, Stockman L: Methods for the rapid identification of mycobacterial species. In: Heifits LB (ed): Clinics in laboratory medicine. WB Saunders, Philadelphia (1996) pp. 603–615

    Google Scholar 

  14. Nolte FS, Metchock B: Mycobacterium. In: Murray PR (ed): Manual of clinical microbiology. American Society for Microbiology, Washington DC (1995) pp. 400–437

    Google Scholar 

  15. Sandin LR: Polymerase chain reaction and other amplification techniques in mycobacteriology. Heifits LB (ed): Clinics in laboratory medicine. WB Saunders, Philadelphia (1996) pp. 617–639

    Google Scholar 

  16. Andersen AB, Hausen EB: Structure and mapping of antigenic domains of protein antigen b, a 38,000 molecular-weight protein ofMycobacterium tuberculosis. Infection and Immunity (1989) 57:2481–2488

    PubMed  Google Scholar 

  17. Sjobring U, Mecklenburg M, Andersen AB, Miorner H: Polymerase chain reaction for detection ofMycobacterium tuberculosis. Journal of Clinical Microbiology (1990) 28:2200–2204

    PubMed  Google Scholar 

  18. Jonas V, Longiaru M: Detection ofMycobacterium tuberculosis by molecular methods. In: Farkas DH (ed): Clinics in laboratory medicine. WB Saunders, Philadelphia (1997) pp. 119–128

    Google Scholar 

  19. Shinnick TM, Jonas V: Molecular approaches to the diagnosis of tuberculosis. In: Bloom BR (ed): Tuberculosis: pathogenesis, protection and control. American Society for Microbiology, Washington DC (1994) pp. 517–530

    Google Scholar 

  20. Brisson Noel A, Gicquel B, Lecossier D, Levy-Frebault V, Nassif X, Hance AJ: Rapid diagnosis of tuberculosis by amplification of mycobacteria! DNA in clinical samples. Lancet (1989) ii:1069–1071

    Google Scholar 

  21. Chiyoji A, Hirano K, Wada M, Kazumi Y, Takahashi M, Fukosawa Y, Yoshimura T, Miyagi C, Goto S: Detection ofMycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe amplifiedMycobacterium tuberculosis direct test. Journal of Clinical Microbiology (1993) 31:3270–3274

    PubMed  Google Scholar 

  22. Miller N, Hernández SG, Cleary TJ: Evaluation of Gen-Probe amplifiedMycobacterium tuberculosis direct test and PCR for direct detection ofMycobacterium tuberculosis in clinical specimens. Journal of Clinical Microbiology (1994) 32:393–397

    PubMed  Google Scholar 

  23. Forbes BA, Hicks KS: Direct detection ofMycobacterium tuberculosis in respiratory specimens in a clinical laboratory by polymerase chain reaction. Journal of Clinical Microbiology (1993) 31:1688–1694

    PubMed  Google Scholar 

  24. Bergmann JS, Woods GL: Clinical evaluation of the Roche Amplicor PCRMycobacterium tuberculosis test for detection ofMycobacterium tuberculosis in respiratory specimens. Journal of Clinical Microbiology (1996) 34:1083–1085

    PubMed  Google Scholar 

  25. Ausina V, Gamboa F, Gazapo E, Manterola JM, Lonca J, Matas L, Manzano JR, Rodrigo C, Cardona PJ, Padilla E: Evaluation of the semiautomated Abbott LCxMycobacterium tuberculosis assay for direct detection ofMycobacterium tuberculosis in respiratory specimens. Journal of Clinical Microbiology (1997) 35:1996–2002

    PubMed  Google Scholar 

  26. Schluger NW, Kinney D, Harkin TJ, Rom WN: Clinical utility of the polymerase chain reaction in the diagnosis of infections due toMycobacterium tuberculosis. Chest (1994) 105:1116–1121

    PubMed  Google Scholar 

  27. Pfyffer GE, Kissling P, Wirth R, Weber R: Direct detection ofMycobacterium tuberculosis complex in respiratory specimens by a target-amplified test system. Journal of Clinical Microbiology (1994) 32:918–923

    PubMed  Google Scholar 

  28. Jonas V, Alden MJ, Curry JI, Kamisango K, Knott CA, Lankford R, Wolfe JM, Moore DF: Detection and identification ofMycobacterium tuberculosis directly from sputum sediments by amplification rRNA. Journal of Clinical Microbiology (1993) 31:2410–2416

    PubMed  Google Scholar 

  29. Dalovisio JR, Montenegro-James S, Kemmerly SA, Genre CF, Chambers R, Greer D, Pankey GA, Failla DM, Haydel KG, Hutchinson L, Lindley MF, Nunez BM, Praba A, Eisenach KD, Cooper ES: Comparison of the amplifiedMycobacterium tuberculosis (MTB) direct test, Amplicor MTB PCR, and IS6110-PCR for detection of MTB in respiratory specimens. Clinical Infectious Diseases (1996) 23:1099–1106

    PubMed  Google Scholar 

  30. Chin DP, Yajko DM, Hadley WK, Sanders CA, Nassos PS, Madej JJ, Hopewell PC: Clinical utility of a commercial test based on the polymerase chain reaction for detectingMycobacterium tuberculosis in respiratory specimens. American Journal of Respiratory and Critical Care Medicine (1995) 151:1872–1877

    PubMed  Google Scholar 

  31. Kennedy N, Gillespie SH, Saruni AO, Kisyombe G, McNerney R, Ngowi FI, Wilson S: Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis. Journal of Infectious Diseases (1994) 170:713–716

    PubMed  Google Scholar 

  32. Van Der Vliet GME, Schepers P, Schukkink RAF: Assessment of mycobacterial viability by RNA amplification. Journal of Clinical Microbiology (1994) 38:1959–1965

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alonso, P., Orduña, A., Bratos, M.A. et al. Clinical evaluation of a commercial ligase-based gene amplification method for detection ofMycobacterium tuberculosis . Eur. J. Clin. Microbiol. Infect. Dis. 17, 371–376 (1998). https://doi.org/10.1007/BF01691563

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01691563

Keywords

Navigation